Giorgio Walter Canonica's research works | Istituto Clinico Humanitas IRCCS (Humanitas) and other places
View of The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service | Global & Regional Health Technology Assessment
Risultati su dupilumab per la rinosinusite cronica con poliposi nasale • NCF